What are the clinical presentations of discitis (inflammation of the intervertebral disc)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Discitis typically presents with back pain that is often severe, persistent, and worsens with movement, and the most recent and highest quality study 1 suggests that MRI is the gold standard for diagnosis, showing decreased disc height, endplate erosions, and enhancement of the disc and adjacent vertebrae.

Key Features of Discitis

  • Back pain that is severe, persistent, and worsens with movement
  • Fever
  • Limited spinal mobility
  • Neurological symptoms such as weakness, numbness, or tingling in the extremities
  • Elevated inflammatory markers (ESR, CRP) and sometimes leukocytosis
  • Blood cultures may be positive in 50-70% of cases

Diagnosis

  • MRI is the gold standard for diagnosis, showing decreased disc height, endplate erosions, and enhancement of the disc and adjacent vertebrae 1
  • CT scans can demonstrate bony destruction
  • Plain radiographs may initially be normal but later show disc space narrowing
  • Biopsy may be necessary to identify the causative organism, commonly Staphylococcus aureus

Treatment

  • Treatment typically involves 6-12 weeks of antibiotics, initially intravenous then oral, based on culture results 1
  • Empiric therapy often includes vancomycin plus a third-generation cephalosporin until culture results guide targeted therapy
  • Pain management, spinal immobilization, and occasionally surgical debridement for abscesses or severe neurological compromise are important components of management
  • Early diagnosis is essential to prevent complications such as spinal deformity, chronic pain, or neurological deficits 1

From the Research

Discitis Presentation

  • Discitis is a serious condition that can present with severe back pain and restriction of spinal movements, as seen in two elderly patients (aged 70 and 80 years) in a study published in 2000 2.
  • The characteristic feature of discitis is the development of increasingly severe back pain, which is not relieved by rest or narcotic analgesics, as described in a study published in 2006 3.
  • Discitis can be caused by pyogenic organisms and can lead to serious complications, such as vertebral osteomyelitis or the formation of an epidural abscess, if left untreated or not properly managed 3, 4.
  • The majority of cases of discitis are caused by Staphylococcus spp (40.3%) and involve the lumbosacral region (52.3%), as reported in a systematic review published in 2019 4.
  • Discitis can also be associated with neurological compromise, abscess development, and segmental instability, which can lead to spinal cord compression and neurological deficits 4.

Clinical Features

  • Severe back pain and restriction of spinal movements are common presenting features of discitis 2, 3.
  • Inflammatory markers are often raised in patients with discitis, which can help in diagnosis 2.
  • Computed tomography (CT) findings can confirm the diagnosis of discitis, as seen in the study published in 2000 2.
  • Abscesses can develop in patients with discitis, which can be treated percutaneously or with open surgery, depending on the location and severity of the abscess 4.

Treatment

  • Antibiotic therapy is often used to treat discitis, with ceftriaxone being a widely favored choice of antibiotic 3, 5.
  • The timing of antibiotic administration is crucial in preventing or treating discitis, and high-performance liquid chromatography can be used to detect the concentration of cephazolin in the plasma and disc 3.
  • A once-daily dose of ceftriaxone 2g can be considered for systemic infections, including spondylodiscitis, with Cutibacterium acnes, using a clinical breakpoint of ≤0.5mg/L 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.